GDNF and Parkinson disease: While it may be premature to consider the implications of GlyNAC supplementation in Parkinson’s disease based on this study which did not measure GDNF specifically in dopaminergic neurons, the findings of this study nevertheless support the need for future research on the effect of GlyNAC supplementation in dopaminergic neurons and signaling pathways.